Two out of three?
23 April 2009
Email
Share
Drug companies routinely bet billions on uncertain odds. Roche gambled by spending $47bn on Genentech just before the results of an important clinical trial were announced. It lost. Roche overpaid by billions, but it was a gamble worth taking.